Literature DB >> 7641643

Post-anaesthetic psychomotor and cognitive function.

K T Korttila1.   

Abstract

Day surgery has a remarkable overall record of safety. To provide safe anaesthesia and as little post-anaesthetic psychomotor and cognitive impairment as possible after longer and more extensive operations performed in ambulatory surgical facilities, we must carefully assess home readiness and instruct patients in such a way that they receive and understand all relevant information. Policies for safe discharge from the hospital are most important for good outcome and have to be followed. If a patient does not have an escort home, the procedure should be cancelled or the patient should be admitted to the hospital. Recommendations not to drive after anaesthesia or sedation vary between 24 and 48 hours, depending on the duration of anaesthesia. It is hoped that the recently introduced short-acting drugs will further improve outcome of day surgery by providing fast exit and early return to normal daily activities.

Entities:  

Mesh:

Year:  1995        PMID: 7641643

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  3 in total

1.  Preoperative splenic artery embolization in children: is it really necessary?

Authors:  Tomasz Stefaniak; Piotr Czauderna; Jarosław Kobiela; Monika Proczko-Markuszewska; Wojciech Makarewicz; Łukasz Kaska; Janusz Głowacki; Andrzej J Łachinski
Journal:  Surg Endosc       Date:  2006-11-14       Impact factor: 4.584

2.  Recovery of dynamic balance after general anesthesia with sevoflurane in short-duration oral surgery.

Authors:  Toshiaki Fujisawa; Eriko Miyamoto; Shigeru Takuma; Makiko Shibuya; Akihiro Kurozumi; Yukifumi Kimura; Nobuhito Kamekura; Kazuaki Fukushima
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

3.  Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery.

Authors:  Kidong Kim; Beob-Jong Kim; Moon-Hong Kim; Seok-Cheol Choi; Sang-Young Ryu
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.